Underutilization of implantable cardioverter defibrillators post coronary artery bypass grafting in patients with systolic dysfunction

PACE - Pacing and Clinical Electrophysiology

Volumn 33, Issue 6, 2010, Pages 727-733

  John, Jerry M ^a   Hussein, Ahmed ^a   Imran, Naser ^a   Durham, Samuel J ^a   Grubb, Blair P ^a   Kanjwal, Yousuf ^a  

^a UNIVERSITY OF TOLEDO MEDICAL CENTER   (United States)

Author keywords

Coronary artery bypass grafting (CABG); Heart failure; Internal cardioverter defibrillator (ICD)

Indexed keywords

ADULT; AGED; ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; REVASCULARIZATION; SYSTOLIC DYSFUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MIDDLE AGED; RETROSPECTIVE STUDY; THERAPY; TREATMENT OUTCOME; UTILIZATION;

AGED; CORONARY ARTERY BYPASS; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77953211746     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2010.02700.x     Document Type: Article

References (22)

1. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death. Structure, function, and time-dependence of risk. Circulation 1992 85:I2-I10.
2. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, et al. Heart disease and stroke statistics-2008 update: A report from the american heart association statistics committee and stroke statistics subcommittee. Circulation 2008 117:e25-e146.
3. Baker DW, Jones R, Hodges J, Massie BM, Konstam MA, Rose EA. Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. JAMA 1994 272:1528-1534.
4. Elefteriades JA, Tolis G, Jr, Levi E, Mills LK, Zaret BL. Coronary artery bypass grafting in severe left ventricular dysfunction: Excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol 1993 22:1411-1417.
5. Moss AJ. MADIT-II and its implications. Eur Heart J 2003 24:16-18.
6. Passamani E, Davis KB, Gillespie MJ, Killip T. A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction. N Engl J Med 1985 312:1665-1671.
7. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006 114:e385-e484.
8. Ruskin JN, Camm AJ, Zipes DP, Hallstrom AP, McGrory-Usset ME. Implantable cardioverter defibrillator utilization based on discharge diagnoses from medicare and managed care patients. J Cardiovasc Electrophysiol 2002 13:38-43.
9. Voigt A, Ezzeddine R, Barrington W, Obiaha-Ngwu O, Ganz LI, London B, Saba S. Utilization of implantable cardioverter-defibrillators in survivors of cardiac arrest in the United States from 1996 to 2001. J Am Coll Cardiol 2004 44:855-858.
10. Clark RE. The STS cardiac surgery national database: An update. Ann Thorac Surg 1995 59:1376-1380 discussion 1380-1371.
11. Weintraub WS, Clements SD, Jr, Crisco LV-T, Guyton RA, Craver JM, Jones EL, Hatcher CR, Jr. Twenty-year survival after coronary artery surgery: An institutional perspective from Emory University. Circulation 2003 107:1271-1277.
12. Abubakar I, Kanka D, Arch B, Porter J, Weissberg P. Outcome after acute myocardial infarction: A comparison of patients seen by cardiologists and general physicians. BMC Cardiovasc Disord 2004 4:14.
13. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004 351:2481-2488.
14. Bigger JT, Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) patch trial investigators. N Engl J Med 1997 337:1569-1575.
15. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005 352:225-237.
16. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002 346:877-883.
17. Goldenberg I, Moss AJ, McNitt S, Zareba W, Hall WJ, Andrews ML, Wilber DJ, et al. Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol 2006 47:1811-1817.
18. Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H, Zareba W, et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 2008 51:288-296.
19. Moss AJ. MADIT-II: Substudies and their implications. Card Electrophysiol Rev 2003 7:430-433.
20. Wilber DJ, Zareba W, Hall WJ, Brown MW, Lin AC, Andrews ML, Burke M, et al. Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation 2004 109:1082-1084.
21. Sanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med 2005 353:1471-1480.
22. Bloomfield DM, Steinman RC, Namerow PB, Parides M, Davidenko J, Kaufman ES, Shinn T, et al. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: A solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation 2004 110:1885-1889.